April 5, 2018 / 7:58 AM / in 18 days

BRIEF-Diasorin Receives FDA Clearance For Liaison Brahms Percent II Gen Assay For Sepsis

April 5 (Reuters) - DIASORIN SPA:

* RECEIVES FDA CLEARANCE FOR LIAISON BRAHMS PERCENT II GEN ASSAY TO DETECT SEVERE BACTERIAL INFECTIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below